Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer
William T. Sause(LDS Hospital), Andrew T. Turrisi(American Society of Clinical Oncology), Patricia Kolesar(RTOG Foundation), Walter J. Curran(Piedmont Atlanta Hospital), Roger W. Byhardt, Robert Livingston(University of Washington), David H. Johnson(National Institutes of Health), A. Rashid Dar(Western University), Ritsuko Komaki(The University of Texas MD Anderson Cancer Center), Samuel G. Taylor(Advocate Illinois Masonic Medical Center), Bahman Emami
Cited by 632
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
|Journal of Clinical Oncology|2003|1.4k
Impact of Cancer-Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition
|The Oncologist|2000|1.3k